
Eiko Fried
Researcher
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Jul 21, 2026
Buyer beware: the limitations of psychedelics research - Eiko Fried
4:32
4:42
4:59
L
4:14And so before going into exploring in more detail all of these shortcomings that now come with us wanting to investigate psychedelics, do you think any of our current colleagues, methods are salvageable? Is there hope? Or do we need to kind of scrape everything and start building afresh?

Eiko FriedGUEST
So I sort of want to agree with you in that the phenomenology, that's something I'm interested in, in these experiences is relevant probably to treatment success.

Eiko FriedGUEST
But I also want to push back a little because this is also the case for exposure therapy, for example, or cognitive behavioral therapy or other psychotherapies where The subject of behavior or feeling or the phenomenology of a current state might impact on treatment success.

Eiko FriedGUEST
That's why we call the paper history repeating because the problems are not new in a way.
10 MINS LATER